Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Tonsillitis II: Management01:26

Tonsillitis II: Management

446
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
446
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

226
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
226
Managing Impressions01:19

Managing Impressions

178
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
178
Management of Insomnia01:19

Management of Insomnia

684
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
684
Angina IV: Management01:26

Angina IV: Management

307
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radioactive Seed Localization for the Resection of Nonpalpable Breast Lesions: A "No Later Than" Date Dosimetric Approach.

Health physics·2026
Same author

"Time to See" in Infantile Nystagmus.

Investigative ophthalmology & visual science·2026
Same author

"Keep the Human Touch": Exploring Perspectives of Older Adults on the Use of Artificial Intelligence (AI) in Healthcare.

Journal of the American Geriatrics Society·2026
Same author

Urinary Incontinence Care in the Academic and Safety-Net Primary Care Settings: Opportunities to Improve Quality of Care.

Urology·2024
Same author

Building Geriatric Trauma Programs in Resource-Constrained Environments: Trauma Quality Improvement Program Guideline Implementation at Two Safety Net Hospitals in Southern California.

The American surgeon·2024
Same author

Informing Dementia Support Programs That Serve Low-Income, Multilingual Communities in a Safety Net Health System: Use of Focus Groups to Identify Specific Needs.

Geriatrics (Basel, Switzerland)·2024

Related Experiment Video

Updated: Feb 13, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

An Update on Menopause Management.

Katherine Ward, Angela Deneris

    Journal of Midwifery & Women'S Health
    |March 10, 2018
    PubMed
    Summary

    Menopause hormone therapy guidelines have evolved since the Women's Health Initiative study. Current recommendations incorporate new data and medications, including selective estrogen receptor modulators, alongside evidence-based alternatives.

    Area of Science:

    • Reproductive Endocrinology
    • Women's Health
    • Pharmacology

    Background:

    • Menopause symptoms prompt many women to seek medical care.
    • Hormone therapy (HT) prescribing recommendations have shifted significantly since 2002.
    • Updated guidelines from major medical societies reflect new analyses and clinical trial data.

    Purpose of the Study:

    • To review current recommendations for hormone therapy in menopause.
    • To discuss new medications available for menopause symptom management.
    • To present evidence-based alternatives to hormone therapy.

    Main Methods:

    • Review of updated guidelines from the North American Menopause Society and American College of Obstetricians and Gynecologists.
    • Analysis of long-term data from the Women's Health Initiative study.
    Keywords:
    gynecologymenopause and midlife healthpharmacologypreventive health care

    More Related Videos

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    13.0K
    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
    09:38

    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

    Published on: September 5, 2025

    931

    Related Experiment Videos

    Last Updated: Feb 13, 2026

    The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
    06:05

    The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

    Published on: February 19, 2021

    1.8K
    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    13.0K
    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
    09:38

    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

    Published on: September 5, 2025

    931
  • Inclusion of emerging data from recent clinical trials.

    • Main Results:

    • Systemic estrogen use in women with a uterus requires progestogen co-administration.
    • Two novel selective estrogen receptor modulators are available for use without a progestogen.
    • Risks and benefits of current hormone therapy approaches are detailed.

    Conclusions:

    • Current menopause management integrates updated HT guidelines and novel pharmacotherapies.
    • Selective estrogen receptor modulators offer new options for women.
    • Evidence-based non-hormonal treatments are also crucial for managing menopause symptoms.